A self-limited blastic proliferation, indistinguishable from acute leukemia except for its disappearance without therapy, has been noted in infants with Down's syndrome. PPO activity was detected by the method of Breton-Gorius3 with a slight modifica tion which was described elsewhere.4 Prior to the fixation using a tannic acid-formal dehyde-glutaraldehyde (TFG) mixture, the specimens were fixed with 0.5% glutaral dehyde in order to avoid precipitation of plasma proteins with TFG mixture. More than 200 blasts were observed and the proportion of PPO positive blasts were calculated.
.
Results
The proportions of PPO-positive blasts and MPO-positive blasts and cell surface phenotyping of blastic cells were shown in Table 1 . 
Discussions
A large proportion of proliferating blasts were positive for PPO activity in all three patients. B!.asts with MPO activity were seen at the proportion of 2 to 12%. As for cell surface phenotyping, sixteen to 42% of blastic cells were positive for TP80. A considerable proportion of blasts were positive for MYIO and/or MY9 in patients No. 1
and No. 2, but blasts positive for MY7 and/or MY4 were rare in these patients. Ac cording to our experience MY10 and/or MY9 may be expressed as megakaryoblasts.6
Therefore it is reasonable to conclude that proliferating blasts in these two patients were mainly megakaryoblastic. In patient No. 3 about thirty percent of blasts were positive for MY7 and MY4. In this patient MPO positive blasts were also seen in a proportion of 11%. Therefore proliferating blasts in patient No. 3 were concluded to be mixed myelo-megakaryoblastic.
The proliferating blasts in TAM usually have been described as myeloblasts.2 Our consensus, together with previous reports, is that, the megakaryocytic or myelomega 
